Postinfarct cardiac remodeling and the substrate for sudden cardiac death: role of oxidative stress and myocardial fibrosis

“…in a heart with well-coupled myocytes, a greater number of myocytes with simultaneous early afterdepolarization and delayed afterdepolarization are required to overcome the electrotonic sink effect…” The biological changes that occur after myocardial infarction (MI) produce gross structural abnormalities in the heart, such as scar tissue, hypertrophy and chamber dilatation, which may be followed by functional deterioration and the clinical symptoms of heart failure or ventricular arrhythmia. Heart failure is a well-known risk factor for ventricular arrhythmia that is associated with significantly higher car diovascular mortality. It may be too late to cure a dysfunctional heart. Therefore, understanding the molecular mechanisms and signaling pathways involved in postMI remodeling can provide useful insights for the very important period of time that follows infarction (the ‘golden therapeutic window’). Infarcted hearts show several important pathological changes that are arrhythmogenic, such as nerve sprouting [1], action potential duration (APD) alternans [2] and a decreased cardiac sodium current [3]. Among the underlying pathophysiologic changes, oxidative stress and myocardial fibrosis are particularly impor tant for several reasons. First, there is strong experimental and clinical evidence for their arrhythmogenicity. Second, there are potential therapeutic options to prevent them. Also, oxidative stress promotes cardiac fibrosis. Finally, oxidative stress and cardiac fibrosis potentiate the arrhyth mogenic effect of each other. This article highlights the role of oxidative stress and myocardial fibrosis in providing the sub strate for sudden cardiac death in infarcted hearts.

[1]  D. Mozingo A Controlled Clinical Trial With Pirfenidone in the Treatment of Pathological Skin Scarring Caused by Burns in Pediatric Patients , 2012 .

[2]  M. Donohue,et al.  Pirfenidone for diabetic nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[3]  S. Sahn,et al.  Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials , 2011, The Lancet.

[4]  M. Semenzato,et al.  Mitochondrial injury and protection in ischemic pre- and postconditioning. , 2011, Antioxidants & redox signaling.

[5]  J. Weiss,et al.  Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine. , 2011, Journal of the American College of Cardiology.

[6]  F. Di Lisa,et al.  Oxidation of myofibrillar proteins in human heart failure. , 2011, Journal of the American College of Cardiology.

[7]  S. Nakamura,et al.  N-acetylcysteine inhibits TNF-alpha, sTNFR, and TGF-beta1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro. , 2009, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[8]  A. Garfinkel,et al.  Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress. , 2009, American journal of physiology. Heart and circulatory physiology.

[9]  Yao Sun Myocardial repair/remodelling following infarction: roles of local factors. , 2008, Cardiovascular research.

[10]  G. Ertl,et al.  Post-infarct remodelling: contribution of wound healing and inflammation , 2008, Cardiovascular research.

[11]  H. Karagueuzian,et al.  Apocynin: a potent NADPH oxidase inhibitor for the management of atrial fibrillation , 2008, Redox report : communications in free radical research.

[12]  J. Manson,et al.  Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. , 2008, JAMA.

[13]  M. Field,et al.  Ventricular Tachycardia AblationCLINICAL PERSPECTIVE , 2008 .

[14]  J. Weiss,et al.  Serum transforming growth factor-beta1 as a risk stratifier of sudden cardiac death. , 2008, Medical hypotheses.

[15]  Frédéric Sacher,et al.  Ventricular Tachycardia Ablation: Evolution of Patients and Procedures Over 8 Years , 2008, Circulation. Arrhythmia and electrophysiology.

[16]  J. Keski‐Oja,et al.  Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. , 2008, Antioxidants & redox signaling.

[17]  D. Rosenbaum,et al.  Mechanisms of arrythmogenic cardiac alternans. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[18]  Ajay M Shah,et al.  Oxidative stress and redox signalling in cardiac hypertrophy and heart failure , 2006, Heart.

[19]  Dudley J Pennell,et al.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[20]  L. Maier,et al.  Blocking Late Sodium Current Reduces Hydrogen Peroxide-Induced Arrhythmogenic Activity and Contractile Dysfunction , 2006, Journal of Pharmacology and Experimental Therapeutics.

[21]  W. Lederer,et al.  Sodium current and arrhythmogenesis in heart failure. , 2005, Heart failure clinics.

[22]  K. Ando,et al.  Redox Regulation of NF-κB Activation: Distinct Redox Regulation Between the Cytoplasm and the Nucleus , 2005 .

[23]  T. Nakano,et al.  Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure. , 2004, American journal of physiology. Heart and circulatory physiology.

[24]  T. Nakano,et al.  Candesartan Prevents Myocardial Fibrosis during Progression of Congestive Heart Failure , 2004, Journal of cardiovascular pharmacology.

[25]  A. Shah,et al.  Role of oxidative stress in cardiac remodelling after myocardial infarction. , 2004, Heart, lung & circulation.

[26]  T. Fukui,et al.  Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction. , 2001, Biochemical and biophysical research communications.

[27]  S. Schoonbroodt,et al.  Oxidative stress interference with the nuclear factor- κB activation pathways , 2000 .

[28]  F. Boomsma,et al.  Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade Prevent Cardiac Remodeling in Pigs After Myocardial Infarction: Role of Tissue Angiotensin II , 2000, Circulation.

[29]  Hiroyuki Tsutsui,et al.  Treatment With Dimethylthiourea Prevents Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction in Mice: Role of Oxidative Stress , 2000, Circulation research.

[30]  T A Denton,et al.  Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. , 2000, Circulation.

[31]  J. Piette,et al.  Oxidative stress interference with the nuclear factor-kappa B activation pathways. , 2000, Biochemical pharmacology.

[32]  S. M. Sims,et al.  Hydrogen peroxide-induced stimulation of L-type calcium current in guinea pig ventricular myocytes and its inhibition by adenosine A1 receptor activation. , 1998, The Journal of pharmacology and experimental therapeutics.

[33]  H. Nakayama,et al.  Effects of hydroxyl radical and sulfhydryl reagents on the open probability of the purified cardiac ryanodine receptor channel incorporated into planar lipid bilayers. , 1998, Biochemical and biophysical research communications.

[34]  V. Ferrans,et al.  Protection from reoxygenation injury by inhibition of rac1. , 1998, The Journal of clinical investigation.

[35]  P. Singal,et al.  Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. , 1997, Circulation.

[36]  R. Singh,et al.  Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3) , 1996, The American journal of cardiology.

[37]  P. Singal,et al.  Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. , 1996, The American journal of pathology.

[38]  M. Daemen,et al.  Collagen remodeling after myocardial infarction in the rat heart. , 1995, The American journal of pathology.

[39]  M. Horackova,et al.  Alterations in electrical and contractile behavior of isolated cardiomyocytes by hydrogen peroxide: possible ionic mechanisms. , 1991, Journal of molecular and cellular cardiology.

[40]  G. Murrell,et al.  Modulation of fibroblast proliferation by oxygen free radicals. , 1990, The Biochemical journal.